Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

AbbVie Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Short-term borrowings	—)	—)	1)	14)	34)
Current portion of long-term debt and finance lease obligations	6,804)	7,191)	4,135)	12,481)	8,468)
Sales rebates	14,304)	13,627)	10,717)	8,254)	7,188)
Dividends payable	2,936)	2,783)	2,680)	2,543)	2,335)
Accounts payable	2,945)	3,688)	2,934)	2,882)	2,276)
Current portion of contingent consideration liabilities	2,589)	1,952)	1,469)	1,249)	—)
Salaries, wages and commissions	1,986)	1,802)	1,371)	1,785)	1,669)
Royalty and license arrangements	527)	360)	412)	661)	483)
Other	6,658)	6,438)	5,819)	5,325)	6,208)
Accounts payable and accrued liabilities	31,945)	30,650)	25,402)	22,699)	20,159)
Current liabilities	38,749)	37,841)	29,538)	35,194)	28,661)
Long-term debt and finance lease obligations, excluding current portion	60,340)	52,194)	59,135)	64,189)	77,554)
Deferred income taxes	2,579)	1,952)	2,190)	3,009)	3,646)
Contingent consideration liabilities	19,077)	17,938)	14,915)	13,638)	12,289)
Liabilities for unrecognized tax benefits	5,049)	6,681)	6,502)	5,970)	5,680)
Income taxes payable	1,261)	2,182)	2,985)	3,442)	3,847)
Pension and other post-employment benefits	1,234)	1,538)	1,638)	3,153)	3,413)
Other	3,508)	3,988)	4,615)	2,498)	2,378)
Other long-term liabilities	30,129)	32,327)	30,655)	28,701)	27,607)
Long-term liabilities	93,048)	86,473)	91,980)	95,899)	108,807)
Total liabilities	131,797)	124,314)	121,518)	131,093)	137,468)
Common stock, $0.01 par value	18)	18)	18)	18)	18)
Common stock held in treasury, at cost	(8,201)	(6,533)	(4,594)	(3,143)	(2,264)
Additional paid-in-capital	21,333)	20,180)	19,245)	18,305)	17,384)
Retained earnings (accumulated deficit)	(7,900)	(1,000)	4,784)	3,127)	1,055)
Accumulated other comprehensive loss	(1,925)	(2,305)	(2,199)	(2,899)	(3,117)
Stockholders’ equity	3,325)	10,360)	17,254)	15,408)	13,076)
Noncontrolling interest	39)	37)	33)	28)	21)
Total equity	3,364)	10,397)	17,287)	15,436)	13,097)
Total liabilities and equity	135,161)	134,711)	138,805)	146,529)	150,565)

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Download chart

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	AbbVie Inc. current liabilities increased from 2022 to 2023 and from 2023 to 2024.
Long-term liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	AbbVie Inc. long-term liabilities decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	AbbVie Inc. total liabilities increased from 2022 to 2023 and from 2023 to 2024.
Stockholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	AbbVie Inc. stockholders’ equity decreased from 2022 to 2023 and from 2023 to 2024.

AbbVie Inc. (NYSE:ABBV)

Balance Sheet: Liabilities and Stockholders’ Equity